Definitive Contract 75N93022C00051
Award Date 9/15/22
Potential Completion Date 9/15/23
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $63,336 firm fixed price delivery order against the Nonclinical Services for Development of Interventional Agents master IDIQ to Sri International. The order is for nonclinical services to support the development of interventional agents for infectious diseases. Performance will take place in West Menlo Park, California over a one year period ending December...
- This firm fixed price definitive contract for $300,000 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Innov8Ai, a for-profit small business, to advance the agency's mission through research and development. The contract is associated with the Small Business Innovation Research Program Phase I solicitation to capture medical misinformation in social media for targeted interdiction using an...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $115,733 firm-fixed-price delivery order contract to Sri International, a non-profit research institute, for nonclinical services to support the development of interventional agents for infectious diseases. The contract has an estimated completion date of April 30, 2024 and is not set aside for any specific business type. Sri International has extensive...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,314,726 delivery order to Sri International, a non-profit research institute, to provide pre-clinical microbiological, safety, toxicology, and pharmacokinetic services. This order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery, indefinite quantity (IDIQ) contract. The period of performance runs through April...
- This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Ividence Inc., a for-profit small business located in Hockessin, Delaware. The contract is for a Phase I Small Business Innovation Research (SBIR) program award, which is part of a larger SBIR solicitation from NIAID and the Centers for Disease Control and Prevention (CDC) covering a wide range...
- This federal contract award, valued at $224,562.96, was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health (NIH). The contract was awarded to Infotech Soft, Inc., a for-profit, woman-owned business, and is a Definitive Contract with a Firm Fixed Price. The work is to be performed in Miami, Florida and the contract has a completion date of July 31, 2018. This appears to be a Small...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 13, 2011, with a ceiling value of $4,399,991.97 for preclinical services in the development of interventional agents for infectious diseases. The order encompasses administrative, technical, and management support activities. Place of performance is Menlo Park, CA. The ultimate completion date is February 15, 2020. Pricing is cost plus fixed fee with no set-aside applied.
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000 definitive contract to Antagen Biosciences Inc., doing business as Antagen Pharmaceuticals, as part of the Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from July 5, 2022 through November 30, 2023 to be performed in Canton, Massachusetts. The award is set aside for...
- This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2,000 firm fixed price delivery order against an unspecified contract vehicle to Lovelace Biomedical Research Institute. The delivery order is for comprehensive and rapid response services to support NIAID's research programs over a one year period from September 2021 through August 2022. The place of performance will be in Bethesda, Maryland. No set aside designation or subcontractors were...